Company Overview - Village Farms International, Inc. has announced its first shipment of Pink Kush to New Zealand through its subsidiary Pure Sunfarms, marking a significant step in its international expansion strategy [2][4] - Pink Kush is recognized as the top-selling dried flower strain in Canada over the past four years, highlighting its popularity and market strength [2][3] Market Expansion - The New Zealand cannabis market is projected to grow at a compound annual growth rate (CAGR) of 58% by 2030, indicating substantial growth potential for medical cannabis products [3] - Medleaf Therapeutics, a New Zealand-based company, will distribute Pink Kush under its 'Bloom' brand, leveraging its established distribution network across clinics and healthcare practitioners [3][5] Strategic Partnerships - The partnership with Medleaf Therapeutics is aimed at enhancing Village Farms' presence in international medical markets, showcasing the company's commitment to expanding its global footprint [4] - Medleaf's focus on market-proven medical cannabis products aligns with Village Farms' strategy to export leading cannabis products to growing international markets [5] Operational Strength - Village Farms operates one of the largest cannabis operations globally through Pure Sunfarms, recognized for being a low-cost greenhouse producer and a best-selling brand in Canada [8] - The company is also involved in various international markets, exporting medical cannabis to countries such as Germany, the UK, Israel, and Australia, while targeting new opportunities in the Asia-Pacific and European regions [9] Future Outlook - Village Farms plans to enter the US high-THC cannabis market, utilizing its extensive greenhouse operations and the expertise gained from its Canadian cannabis success [10] - The company is focused on expanding its international presence with additional export contracts and strategic investments in operating assets [9]

Company Overview - Village Farms International, Inc. is a vertically integrated supplier specializing in Controlled Environment Agriculture, focusing on high-value, high-growth plant-based Consumer Packaged Goods [4] - The company is a leading fresh produce supplier in the US and Canada and is expanding into the cannabis and CBD markets [4] Cannabis Operations - In Canada, Village Farms' subsidiary Pure Sunfarms is one of the largest cannabis operations globally and a top-selling brand [5] - The company holds an 80% stake in Rose LifeScience, a prominent cannabis product commercialization expert in Québec [5] - Village Farms is exporting medical cannabis from its EU GMP certified facility in Canada to various international markets, including Germany, the UK, Israel, and Australia [6] US Market Strategy - The company plans to enter the US high-THC cannabis market, leveraging its extensive greenhouse operations in West Texas, which spans over 5.5 million square feet [7] - Balanced Health Botanicals, a subsidiary, is a leading CBD and hemp-derived brand and e-commerce platform in the US [7] Clean Energy Initiatives - Village Farms Clean Energy, in partnership with Terreva Renewables, generates clean energy from landfill gas, significantly reducing greenhouse gas emissions in Vancouver [8] - The partnership contributes to a reduction of 475,000 metric tons of CO2 emissions annually, equivalent to removing over 100,000 vehicles from the road [8]

Industry Overview - The marijuana sector is experiencing volatility, with investors needing to conduct thorough research to develop effective investment strategies [1][2] - The industry is expected to continue facing ups and downs in 2025, driven by federal reform efforts and cannabis approval initiatives [2] Company Highlights - Village Farms International, Inc. produces and markets greenhouse-grown vegetables and has expanded its operations to include in-house production of CBD gummies through its subsidiary, Balanced Health Botanicals [4][6] - Canopy Growth Corporation is involved in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes across multiple countries [9][10] Financial Performance - Canopy Growth Corporation reported a 5% decrease in net revenue for Q3 FY2025 compared to the same quarter in the previous year [12] - The gross margin for Canopy Growth decreased by 400 basis points to 32% in Q3 FY2025 [12] - The operating loss from continuing operations for Canopy Growth was $24 million in Q3 FY2025, showing a 61% improvement compared to Q3 FY2024 [12] - Adjusted EBITDA loss for Canopy Growth was $3 million in Q3 FY2025, reflecting a 61% year-over-year improvement [12]

DENVER, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Balanced Health Botanicals' CBDistillery™, a wholly-owned subsidiary of Village Farms International (NASDAQ:VFF) and one of the best-selling CBD brands in the United States, today announced that its full range of hemp-derived gummies is now manufactured in-house at its GMP-certified facility south of Denver, Colorado. This internalization demonstrates the company's commitment to offering quality wellness products while enabling greater innovation, agility, and inven ...

– Company meets previous guidance on commencement of sales with deliveries of first flower harvest to coffeeshops –ORLANDO, Fla. and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced it has begun processing orders and deliveries at its wholly-owned Leli Holland subsidiary (“Leli”) in the Netherlands, meeting its previously-disclosed guidance on its timeline to commencement of sales in the Dutch ma ...

– Company views delay as imperative administrative step and symbolic win for industry against conflicted DEA – – Company condemns agency wrongdoing and commends judge for harsh criticism of government officials – – CEO Michael DeGiglio affirms commitment to fight for reform; calls on Trump administration to correct past failures – ORLANDO, Fla. and VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today issued a ...

– Parties urge the court to take immediate corrective action in response to renewed Request – – Filing asserts that DEA is using authority in these proceedings to thwart a proposal it vehemently opposes – – New evidence of widespread DEA wrongdoing necessitates Agency's removal from participation in proceedings – ORLANDO, Fla. and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF) and Hemp for Victory (collectively ...

DELTA, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Pure Sunfarms Corp. (“Pure Sunfarms”), a wholly owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF) and a leading global cannabis operation with top-performing brands, announces the launch of The Canna Czar presented by Soar. This twax blunt honours the artistry of the legacy Canna Czar through its recreation for today’s consumer. The Canna Czar is a 2.1g specialty twax blunt. The layered infused blunt is handmade with a golden shatt ...

Village Farms International (NASDAQ:VFF) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Michael DeGiglio - President and CFO Stephen Ruffini - EVP and CFO Ann Gillin Lefever - COO Conference Call Participants Aaron Grey - Alliance Global Partners Eric Des Lauriers - Craig Hallum Capital Group Michael Regan - Excelsior Equities Doug Cooper - Beacon Securities Pablo Zuanic - Zuanic & Associates Brenna Cunnington - ATB Capital Markets Operator Good morning, ladies and gentlem ...

Financial Data and Key Metrics - Total sales grew 20% year-over-year to $83.4 million, driven by strong growth in both Canadian cannabis and fresh produce segments [29] - Net loss narrowed to CAD 800,000 or CAD 0.01 per share from a CAD 1.3 million loss last year, with positive net income contributions from both Canadian cannabis and Fresh Produce [29] - Consolidated adjusted EBITDA was positive CAD 5.3 million, up 65% from CAD 3.2 million for Q3 last year [29] - Fresh Produce sales increased 20% year-over-year to $42.8 million, with gross margin improving by 400 basis points to 8% [9][30] - Canadian cannabis total net sales grew 29% year-over-year to CAD 15 million, with positive adjusted EBITDA of CAD 6.5 million and operating cash flow of CAD 6.1 million [11][32] Business Line Performance - Fresh Produce segment delivered positive adjusted EBITDA of $2.3 million and net income of $0.4 million, driven by higher volumes and improved pricing [9][30] - Canadian cannabis retail branded sales grew 22% to CAD 37.2 million, while non-branded sales increased 68% to CAD 10.1 million [11][33] - International medical sales doubled year-over-year, with strong growth in Germany, Australia, and the UK [11] - U S cannabis sales were CAD 3 9 million with a gross margin of 63% impacted by regulatory challenges in certain states [36] Market Performance - The company holds the 1 market share in Ontario and Quebec, Canada's two most populous provinces, and maintains the 1 position in flower with a 2 7% increase in market share during Q3 [13] - In the German market, the company's strains are ranked 1 and 3, reflecting strong international customer reception [12] - The company improved its market position in pre-rolls from 4 to 2 nationally, with a 2 3% increase in market share [13] Strategic Direction and Industry Competition - The company is focusing on higher ROI opportunities, particularly in international markets like Europe, while being cautious about capital allocation in Canada due to high excise taxes [23][53] - The company is expanding its presence in the Netherlands, with the Leli Holland subsidiary expected to begin sales in Q1 2025, targeting a EUR 3 billion to EUR 3 5 billion market opportunity [25][26] - The company is prioritizing profitability over volume in Canada, moving away from lower-margin SKUs and raising prices on others [21] Management Commentary on Operating Environment and Future Outlook - Management highlighted the challenges of excise taxes in Canada, which totaled CAD 24 million in Q3 and CAD 78 million year-to-date, impacting capital allocation decisions [35] - The company is optimistic about the potential for cannabis rescheduling in the U S and is participating in the DEA's upcoming hearing on the matter [44][46] - Management expressed confidence in the stabilization of the U S cannabis market and plans to invest in growth initiatives, including new SKUs and innovative product offerings [18][37] Other Important Information - The company completed construction of its indoor cultivation facility in the Netherlands and began cultivation in October, with first sales expected in Q1 2025 [25] - The company's Village Farms Clean Energy project generated net income of CAD 300,000 in Q3, with royalty payments providing incremental profits [38] - The company ended Q3 with cash of CAD 28 7 million and working capital of CAD 65 4 million, with total term debt of CAD 43 million [39] Q&A Session Summary Question: Allocation of product between Canada and international markets - The company is focusing on higher-margin markets internationally, particularly in Europe, while being cautious about expanding capacity in Canada due to high excise taxes and overcapacity [50][53] - The company is moving away from lower-margin SKUs in Canada and raising prices where possible, with a focus on profitability over volume [51] Question: Impact of stock-outs on Canadian cannabis sales - The stock-outs were due to higher-than-expected demand and internal supply chain issues, with normalization expected by Q1 2025 [56] Question: Pricing strategy in Canada - The company is focusing on SKU-by-SKU and brand-by-brand pricing opportunities, with no plans for across-the-board price increases [60][61] Question: Cost structure and profitability of the Netherlands facility - The company is confident in the profitability of the Netherlands facility, with expected pricing of EUR 6 per gram and no excise tax, leading to higher margins compared to Canada [64][65] Question: Market share in Canada - The company holds the 1 market share in Ontario and Quebec, with 4 in BC and 6 in Alberta, aiming to maintain a top-three position in Canada [74][75] Question: Growth outlook for the Canadian cannabis market - The overall Canadian cannabis market growth is expected to slow to mid-single-digits, with the company focusing on innovation and market share gains [77] Question: Netherlands market potential and capacity expansion - The company expects to ramp up to full capacity of 2,000 kilos of dry flower by Q2 2025, with strong demand expected to sell out inventory quickly [82][83] Question: Potential for M&A in international markets - The company is open to M&A opportunities in international markets, particularly in Europe, to gain more control over the route to market and vertical integration [93][95] Question: Impact of recent U S election results on cannabis rescheduling - Management is optimistic about the potential for cannabis rescheduling in the U S, citing bipartisan support and the health and wellness benefits of cannabis [113][115] Question: Gross margin decline in Canadian cannabis - The gross margin decline was primarily due to the mix of B2B sales, with branded product margins returning to the 30%-40% target range [110]